Semipermeable hollow fiber membranes in hepatocyte bioreactors: A prerequisite for a successful bioartificial liver?

Artificial Organs

Volumn 21, Issue 11, 1997, Pages 1177-1181

  Flendrig, Leonard M ^a,b   Te Velde, Anje A ^a   Chamuleau, Robert A F M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Bioartifical liver; Bioreactor; Hepatocytes; Hollow fibers; Liver ischemia; Liver support; Oxygenator

Indexed keywords

BIOCONVERSION; BIOREACTORS; BLOOD; FIBERS; MASS TRANSFER; WEAVING;

BIOARTIFICAL LIVER; BIOARTIFICIAL LIVER; BIOREACTOR; HEPATOCYTES; HOLLOW FIBER; HOLLOW-FIBRE MEMBRANE; LIVER ISCHEMIA; LIVER SUPPORT; OXYGENATOR; SEMIPERMEABLE HOLLOW FIBERS;

ARTIFICIAL ORGANS;

ANIMAL CELL; ARTIFICIAL LIVER; BIOREACTOR; CELL SURVIVAL; CONFERENCE PAPER; LIVER CELL CULTURE; LIVER FAILURE; MEMBRANE; MEMBRANE PERMEABILITY; MEMBRANE STRUCTURE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0030733672     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.1997.tb00471.x     Document Type: Conference Paper

References (22)

1. Sielaff TD, Hu MY, Amiot B, Rollins MD, Rao S, McGuire B, Bloomer JR, Hu W-S, Cerra FB. Gel-entrapment bioartificial liver therapy in galactosamine hepatitis. J Surg Res 1995; 59:179-84.
2. Uchino J, Tsuburya T, Kumagai F, Hase T, Hamada T, Komai T, Funatsu A, Hashimura K, Nakamura K, Kon T. A hybrid artificial liver composed of multiplated hepatocyte monolayers. ASAIO Trans 1988;34:972-7.
3. Jauregui HO, Mullon CJ-P, Trenkler D, Naik S, Santangini H, Press P, Muller TE, Solomon BA. In vivo evaluation of a hollow fiber liver assist device. Hepatology 1995;21:460-9.
4. Knazec RA, Gullino PM, Kohler PO, Dedrick RL. Cell culture on artificial capillaries: an approach to tissue growth in vitro. Science 1972;178:65-7.
5. Wolf CF, Munkelt BE. Bilirubin conjugation by an artificial liver composed of cultured cells and synthetic capillaries. ASAIO Trans 1975;21:16-27.
6. Sussman NL, Gislason GT, Conlin CA, Kelly JH. The Hepatix extracorporeal liver assist device: Initial clinical experience. Artif Organs 1994;18:390-6.
7. Takeshita K, Ishibashi H, Suzuki M, Yamamoto T, Akaike T, Kodama M. High cell-density culture system of hepatocytes entrapped in a three-dimensional hollow fiber module with collagen gel. Artif Organs 1995;19:191-3.
8. Chen SC, Hewitt WR, Watanabe FD, Eguchi S, Kahaku E, Middleton Y, Rozga J, Demetriou AA. Clinical experience with a porcine hepatocyte-based liver support system. Int J Artif Organs 1996;19:664-6.
9. Gelach JC. Development of a hybrid liver support system: A review. Int J Artif Organ 1996;19:645-54.
10. Catapano G. Mass transfer limitations to the performance of membrane bioartificial liver support systems. Int J Artif Organs 1996;19:18-35.
11. Flendrig LM, La Soe JW, Jörning GG, Steenbeek A, Karlsen OT, Bovée WMMJ, Ladiges NCJJ, te Velde AA, Chamuleau RAFM. In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound non-woven polyester matrix for hepatocyte culture as small aggregates. J Hepatotogy 1997;26:1379-92.
12. te Velde AA, Ladiges NCJJ, Flendrig LM, Chamuleau RAFM. Functional activity of isolated pig hepatocytes attached to different extracellular matrix substrates. Implications for application of pig hepatocytes in a bioartificial liver. J Hepatology 1995;23:184-92.
13. Lee SH, Fischer B. Portacaval shunt in the rat. Surgery 1961; 50:668-72.
14. Nyberg SL, Platt JL, Shirabe K, Payne WD, Hu W-S, Cerra FB. Immunoprotection of xenocytes in a hollow fiber bioartificial liver. ASAIO J 1992;38:M463-7.
15. te Velde AA, Flendrig LM, Ladiges NCJJ, Chamuleau RAFM. Immunological consequences of the use of xenogeneic hepatocytes in a bioartificial liver for acute hepatic failure, Int J Artif Organs 1997;20:229-33.
16. Willaert RG, Baron GV, De Backer L. Mass transfer in immobilized cell systems. In: Willaert RG, Baron GV, De Backer L, eds., Immobilized living cell systems. Chichester: John Wiley & Sons, 1996;21-45.
17. Brotherton JD, Chau PC. Protein-free human-human hybridoma cultures in an intercalated-spiral alternate-dead-end hollow fiber bioreactor. Biotech Bioeng 1995;47:384-400.
18. Knazec RA, Gullino PM, Fraenkel DS: Patent # U.S. 184922, January 22, 1980.
19. Gerlach J, Klöppel K, Stoll P, Vienken J, Müller C. Gas supply across membranes in bioreactors for hepatic culture. Artif Organs 1990;14:328-33.
20. Bader A, Knop E, Böker K, Frülauf N, Schüttier W, Olderhafer K, Burkhard R, Pichlmayr R, Swing K-F. A novel bioreactor design for in vitro reconstruction of in vivo liver characteristics. Artif Organs 1995;19:368-74.
21. Baquerizo A, Mhoyan A, Shirwan H, Swensson J, Busuttil RW, Demetriou AA, Cramer DV. Xenobody response of patients with severe acute liver failure exposed to porcine antigens following treatment with a bioartificial liver. Transplant Proc 1997;29:964-5.
22. Willems M, Roskams T, Moshage H, Roels L, Desmet VJ, Yap SH. Immortalized human liver cell lines with phenotypical characteristics of hepatoblast and/or biliary epithelial cells: An in vitro model for the study of liver cell-specific functions. Transplantology 1994;5:151-9.